HMGCR and cancer: In clinical studies, elevated cholesterol is strongly associated with high cancer risk, worse outcomes, and resistance to chemotherapy [14,15], and statin, a cholesterol-lowering agent and inhibitor of HMG-CoA reductase, decreases cancer risk and has antitumor effects [16].